These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1478779)

  • 1. A rational design of synthetic peptide vaccine with a built-in adjuvant. A modular approach for unambiguity.
    Defoort JP; Nardelli B; Huang W; Tam JP
    Int J Pept Protein Res; 1992; 40(3-4):214-21. PubMed ID: 1478779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipophilic multiple antigen peptide system for peptide immunogen and synthetic vaccine.
    Huang W; Nardelli B; Tam JP
    Mol Immunol; 1994 Oct; 31(15):1191-9. PubMed ID: 7935506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macromolecular assemblage in the design of a synthetic AIDS vaccine.
    Defoort JP; Nardelli B; Huang W; Ho DD; Tam JP
    Proc Natl Acad Sci U S A; 1992 May; 89(9):3879-83. PubMed ID: 1349173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of cross-reactive cytotoxic T-lymphocyte responses specific for HIV-1 gp120 using saponin adjuvant (QS-21) supplemented subunit vaccine formulations.
    Newman MJ; Wu JY; Gardner BH; Anderson CA; Kensil CR; Recchia J; Coughlin RT; Powell MF
    Vaccine; 1997 Jun; 15(9):1001-7. PubMed ID: 9261947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immune responses induced by in vivo priming with a lipid-conjugated multimeric antigen peptide.
    Nardelli B; Tam JP
    Immunology; 1993 Jul; 79(3):355-61. PubMed ID: 8104882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid.
    Borges E; Wiesmüller KH; Jung G; Walden P
    J Immunol Methods; 1994 Aug; 173(2):253-63. PubMed ID: 7519223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of a complete synthetic peptide-based AIDS vaccine with a built-in adjuvant.
    Nardelli B; Defoort JP; Huang W; Tam JP
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1405-7. PubMed ID: 1466968
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunogenicity of synthetic HIV-1 V3 loop peptides by MPL adjuvanted pH-sensitive liposomes.
    Chang JS; Choi MJ; Kim TY; Cho SY; Cheong HS
    Vaccine; 1999 Mar; 17(11-12):1540-8. PubMed ID: 10195791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on in vivo induction of HIV-1 envelope-specific cytotoxic T lymphocytes by synthetic peptides from the V3 loop region of HIV-1 IIIB gp 120.
    Nehete PN; Casement KS; Arlinghaus RB; Sastry KJ
    Cell Immunol; 1995 Feb; 160(2):217-23. PubMed ID: 7720083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research Initiative.
    Bartlett JA; Wasserman SS; Hicks CB; Dodge RT; Weinhold KJ; Tacket CO; Ketter N; Wittek AE; Palker TJ; Haynes BF
    AIDS; 1998 Jul; 12(11):1291-300. PubMed ID: 9708408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01.
    Fomsgaard A; Karlsson I; Gram G; Schou C; Tang S; Bang P; Kromann I; Andersen P; Andreasen LV
    Vaccine; 2011 Sep; 29(40):7067-74. PubMed ID: 21767590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-adjuvanting vaccine against group A streptococcus: application of fibrillized peptide and immunostimulatory lipid as adjuvant.
    Azmi F; Ahmad Fuaad AA; Giddam AK; Batzloff MR; Good MF; Skwarczynski M; Toth I
    Bioorg Med Chem; 2014 Nov; 22(22):6401-8. PubMed ID: 25438764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses.
    Oseroff C; Sette A; Wentworth P; Celis E; Maewal A; Dahlberg C; Fikes J; Kubo RT; Chesnut RW; Grey HM; Alexander J
    Vaccine; 1998 May; 16(8):823-33. PubMed ID: 9627940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candidate HIV type 1 multideterminant cluster peptide-P18MN vaccine constructs elicit type 1 helper T cells, cytotoxic T cells, and neutralizing antibody, all using the same adjuvant immunization.
    Ahlers JD; Dunlop N; Pendleton CD; Newman M; Nara PL; Berzofsky JA
    AIDS Res Hum Retroviruses; 1996 Mar; 12(4):259-72. PubMed ID: 8906986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strong immunogenicity of a multicomponent peptide vaccine developed with the branched lysine oligopeptide method for human immunodeficiency virus infection.
    Okuda K; Kaneko T; Yamakawa T; Tanaka S; Shigematsu T; Yamamoto A; Hamajima K; Nakajima K; Kawamoto S; Phanuphak P
    J Mol Recognit; 1993 Sep; 6(3):101-9. PubMed ID: 8060667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral administration of an antigenic synthetic lipopeptide (MAP-P3C) evokes salivary antibodies and systemic humoral and cellular responses.
    Nardelli B; Haser PB; Tam JP
    Vaccine; 1994 Nov; 12(14):1335-9. PubMed ID: 7856301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A peptide carrier with a built-in vaccine adjuvant: construction of immunogenic conjugates.
    Krikorian D; Panou-Pomonis E; Voitharou C; Sakarellos C; Sakarellos-Daitsiotis M
    Bioconjug Chem; 2005; 16(4):812-9. PubMed ID: 16029022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and construction of a novel multiple peptide conjugate system: strategy for a subunit vaccine design.
    Boykins RA; Joshi M; Syin C; Dhawan S; Nakhasi H
    Peptides; 2000 Jan; 21(1):9-17. PubMed ID: 10704714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress toward an artificial vaccine for HIV: identification of helper and cytotoxic T-cell epitopes and methods of immunization.
    Berzofsky JA
    Biotechnol Ther; 1991; 2(1-2):123-35. PubMed ID: 1726961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.